Lincoln National Corp’s Atossa Therapeutics ATOS Stock Holding History

Lincoln National Corp’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-689	Closed	-$7.5K	–	1023
2023 Q1	$7.5K	Hold	689	–	–	﹤0.01%	984
2022 Q4	$5.46K	Hold	689	–	–	﹤0.01%	928
2022 Q3	$9K	Hold	689	–	–	﹤0.01%	867
2022 Q2	$11K	Hold	689	–	–	﹤0.01%	857
2022 Q1	$13K	Hold	689	–	–	﹤0.01%	906
2021 Q4	$17K	Hold	689	–	–	﹤0.01%	888
2021 Q3	$34K	Hold	689	–	–	﹤0.01%	857
2021 Q2	$65K	Sell	689 -178	-21%	-$9.42K	﹤0.01%	847
2021 Q1	$28K	Buy	+867	New	+$31.7K	﹤0.01%	799

Other funds holding ATOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return